Most developed countries have enacted some kind of regulation to ensure basic levels of health and environmental protection in relation to the use of potentially hazardous GMOs in domestic cultivation, commerce and trade. In contrast, most developing countries lack these legal safeguards or lack the capacity and/or the resources to implement existing regulations or policies. This lack of regulatory preparedness and/or lack of implementation puts developing countries under increasing pressure to produce, import and use modern biotechnology products, especially transgenic crops.
Criticisms from diverse social sectors concerning the risks of GM technological developments are frequently dismissed as unfounded and irrational, based on a supposed lack of understanding of scientific and commercial issues. But despite efforts by governments and industry to "educate" and "inform" public opinion about the benefits of products and services derived from modern biotechnology, opposition to these products persists. Potential risks and negative consequences to health are the basis of most people's concern. Consumers possess a clear understanding of the concerns they hold and their demands, far from being irrational, are quite pragmatic.
You received this message because you are subscribed to the "USA-Africa Dialogue Series" moderated by Toyin Falola, University of Texas at Austin.
For current archives, visit http://groups.google.com/group/USAAfricaDialogue
For previous archives, visit http://www.utexas.edu/conferences/africa/ads/index.html
To post to this group, send an email to USAAfricaDialogue@googlegroups.com
To unsubscribe from this group, send an email to USAAfricaDialogue-
unsubscribe@googlegroups.com
No comments:
Post a Comment